C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings

Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
12/2002
12/04/2002	EP1261336A2 Il-8 receptor antagonists
12/04/2002	EP1261329A2 Il-8 receptor antagonists
11/2002
11/28/2002	WO2002094820A1 Crystalline salts of 2-(4-{2-[2-hydroxy-3-(2-thiophen-2-yl-phenoxy)-propylamino]-2-methyl-propyl}-phenoxy)-nicotinonitrile
11/28/2002	WO2002094791A1 Diamide invertebrate pest control agents containing a non-aromatic heterocyclic ring
11/28/2002	US20020177598 Inhibit activity of chemokines, macrophage inflammatory protein-1 (MIP-1 alpha) and RANTES; 1-((4-chlorophenoxy)methyl)-carbonyl-2-methyl-4-(4-fluorobenzyl)piperazine for example
11/28/2002	DE10125432A1 New benzoyl-substituted aliphatic ketones or aldehydes, useful as herbicides or fungicides, especially as pre- and post-emergence selective herbicides against a broad spectrum of weeds
11/27/2002	EP1259494A1 Aryloxyacetic acids for diabetes and lipid disorders
11/27/2002	EP1216125A4 A homogenization enhancing thermoplastic foam extrusion screw
11/27/2002	CN1382140A Neurotrophic pyrrolidines and piperidines and related compositions containing them
11/27/2002	CN1382139A Method and intermediate for preparing is-a-oxazole formylamine and its analogue
11/26/2002	CA2055174C Process for the synthesis of alpha-((dialkylamino) substituted-methylene)-beta-oxo-(substituted) propanenitriles
11/21/2002	WO2002092585A1 Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
11/21/2002	WO2002092574A1 Substituted benzoylcyclohexenones and their use as herbicidal agents
11/21/2002	WO2002092550A1 Thyroid hormone receptor antagonists for cardiac and metabolic disorders ii
11/21/2002	WO2002092094A1 Crystalline isoxazole derivative and medical preparation thereof
11/21/2002	US20020173663 Agonists of peroxisome proliferator activated receptor (PPAR) alpha and/or gamma; benzisoxazole compounds; e.g. ((5,7-dipropyl-3-trifluoromethyl-1,2-benzisoxazol-6-yl)oxy)acetic acid, methyl ester
11/21/2002	US20020173500 Hypotensive agents; antiischemic agents
11/21/2002	US20020173424 Heterocyclyl-substituted benzoylcyclohexandiones, their preparation, and their use as herbicides
11/21/2002	DE10138576A1 New substituted benzoylcyclohexenone derivatives useful as antimicrobials and herbicides, especially for selective application in transgenic crops
11/21/2002	CA2447416A1 Substituted benzoylcyclohexenones and their use as herbicidal agents
11/21/2002	CA2446747A1 Thyroid hormone receptor antagonists for cardiac and metabolic disorders ii
11/20/2002	EP1258484A1 Novel isoxazole and thiazole compounds and use thereof as drugs
11/20/2002	EP1257270A1 A method for synthesizing leflunomide
11/20/2002	EP1165472A4 Methods for the preparation of biphenyl isoxazole sulfonamides
11/20/2002	EP0920422B1 Crytalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide
11/14/2002	WO2002090336A1 Substituted arylketones
11/14/2002	US20020169203 Modulators of all three classes of calcium channel blocker subtypes (Small, Intermediate and Big conductance K channel (SK, IK and BK)) comprising malonate esters and nitriles; respiratory, brain, cardiovascular, urogenital disorders
11/14/2002	DE10136449A1 Substituierte Arylketone Substituted aryl ketones
11/14/2002	CA2449187A1 Substituted arylketones
11/13/2002	CN1379767A Isoxazolecarboxamide derivatives
11/13/2002	CN1379669A Valdecoxib compositions
11/12/2002	US6479529 Antioxidant stabilizer system for pharmaceutical formulations
11/12/2002	US6479524 To prolong the thrombin time
11/12/2002	US6479519 Inhibitors of cell adhesion; treatment of asthma or inflammatory bowel disease
11/12/2002	CA2324959C Phthalimido compounds as intermediates for producing substance p receptor antagonists
11/12/2002	CA2018564C 4,5,5a,6-tetrahydro-3h-isoxazolo¬5,4,3-kl\|acridines derivatives, a process for their preparation and their use as medicaments
11/07/2002	WO2002088094A1 2-iminoimidazole derivatives (1)
11/07/2002	WO2002088092A1 2-iminoimidazole derivative (2)
11/07/2002	WO2002064546A3 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/07/2002	WO2001036365A3 Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
11/07/2002	US20020165400 Antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex; thrombolytic agents
11/07/2002	US20020165398 Amino-thiophene-amido derivatives
11/07/2002	US20020165236 Such as 3-(3-(4-(4-sulfamoyl-benzylsulfamoyl-phenyl)-ureido)-benzamidine for treatment of malaria
11/07/2002	US20020165219 Novel heterocycles useful in the treatment of benign prostatic hyperplasia
11/06/2002	EP1254899A2 Piperazine derivatives and their use as anti-inflammatory agents
11/06/2002	EP1254895A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
11/06/2002	EP1253924A1 Nitrate salts of antimicrobial agents
11/06/2002	EP0920421B1 Isoxazoline derivatives useful as antimicrobials
11/06/2002	EP0898566B1 Substituted benzylamines and their use for the treatment of depression
11/06/2002	CN1378472A Synergy between low molecular weight heparin and platelet aggregation inhibitor, providing combination therapy for prevention and treatment of various thromboembolic disorders
11/05/2002	US6476264 N-(4-carbamimidoyl-phenyl)-glycine derivatives
11/05/2002	US6476226 Isoxazoline fibrinogen receptor antagonists
11/05/2002	CA2038029C 1-alkyl-, 1-alkenyl- and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds, a process and intermediates for their preparation and theeir use as medicaments
11/04/2002	WO2004001058A2 Transcription factor modulating compounds and methods of use thereof
10/2002
10/31/2002	WO2002085855A1 2-iminopyrrolidine derivatives
10/31/2002	WO2002085850A1 Cyclic amidine derivative
10/31/2002	US20020161237 (Z)-2-((2-bromo-4-(((3-hydroxybenzyl)amino)carbonyl)benzoyl) -amino)pent-2-enoic acid, for example; useful for treating psoriasis
10/31/2002	US20020161012 Treatment of obstructive syndromes of the lower urinary tract, including benign prostatic hyperplasia, treatment of lower urinary tract symptoms
10/31/2002	US20020160465 Enantioselective enzymatic aminolysis of a racemic 2-isoxazolylacetate alkyl ester
10/30/2002	CN1377344A Inhibitor of cysteinyl aspartic acid proteinase
10/30/2002	CN1377336A Carboxylic acid derivatives and drugs containing the same
10/30/2002	CN1377259A ACE-2 inhibiting compounds and methods of use thereof
10/30/2002	CN1093537C Process for preparing composition containing 4-benzoyl-iso-oxazole derivative
10/29/2002	US6472412 Compounds as PDE IV and TNF inhibitors
10/29/2002	US6472386 Cyclic diamine compound with 5-membered ring groups
10/24/2002	WO2002083655A1 Prodrugs of cox-2 inhibitors
10/24/2002	WO2002083624A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
10/24/2002	WO2002083622A2 Novel aminophenyl ketone derivatives
10/24/2002	WO2002083177A1 Orally deliverable pharmaceutical composition comprising a drug of low water solubility (cox-2 inhibitor), a solvent, a fatty acid and an organic amine
10/24/2002	WO2002083128A1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and method
10/24/2002	WO2001040221A3 Cyclopropyl-anellated 3-(4,5-dihydroisoxazol-3-yl)-substituted benzoylpyrazoles as herbicides
10/24/2002	US20020156290 Herbicides
10/24/2002	US20020156050 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors
10/24/2002	CA2444465A1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and method
10/24/2002	CA2444267A1 Prodrugs of cox-2 inhibitors
10/24/2002	CA2444220A1 Orally deliverable pharmaceutical composition comprising a drug of low water solubility (cox-2 inhibitor), a solvent, a fatty acid and an organic amine
10/23/2002	EP1251128A1 Cyclohexylamine derivatives as subtype selective N-methyl-D-aspartate antagonists
10/23/2002	EP1251126A2 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
10/23/2002	CN1376146A Solid-state form of celecoxil having enhanced bioavailability
10/23/2002	CN1093124C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma
10/22/2002	US6469176 Method and novel intermediate products for producing isoxazolin-3-yl-acylbenzenenes
10/17/2002	WO2002081428A1 Benzene compound and salt thereof
10/17/2002	WO2002081398A2 Additives for building industry obtained from by-products and process for their production
10/17/2002	WO2002080927A1 Use of selective cox-2 inhibitors for the treatment of urinary incontinence
10/17/2002	WO2002080912A1 Reconstitutable parenteral composition containing a cox-2 inhibitor
10/17/2002	WO2002032884A3 Methods for the preparation of biphenyl isoxazole sulfonamides
10/17/2002	WO2001041760A8 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
10/17/2002	US20020151570 Thiosulfonic acid S-esters as agents for protecting material
10/17/2002	CA2443031A1 Use of selective cox-2 inhibitors for the treatment of urinary incontinence
10/16/2002	EP1249233A1 Npyy5 antagonists
10/16/2002	EP1248612A1 Novel compounds and compositions as protease inhibitors
10/16/2002	EP0934316B1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
10/16/2002	EP0542136B1 1-[(1,4-benzodioxanyl)alkyl]-4-(heteroaryl) piperidines, piperazines and pyrrolidines as antipsychotic agents
10/16/2002	CN1374947A Synthetic reoutes for the preparation of rhionvirus protease inhibitor and key intermediates
10/16/2002	CN1092648C Isoxazole derivatives and their use as herbicides
10/15/2002	US6465513 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
10/15/2002	US6465456 For therapy of bacterial diseases
10/10/2002	WO2002078626A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002	WO2002078625A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002	WO2002078447A1 Preparation of ketones from aldehydes

1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 115